LakeShore Biopharma Company Insiders
| LSBPW Stock | 0.04 0.01 28.33% |
LakeShore Biopharma employs about 758 people. The company is managed by 8 executives with a total tenure of roughly 1769 years, averaging almost 221.0 years of service per executive, having 94.75 employees per reported executive. Recap of LakeShore Biopharma's management performance can provide insight into the venture performance.
LakeShore |
LakeShore Biopharma Management Team Effectiveness
Return On Tangible Assets is likely to drop to -0.32 in 2024. Return On Capital Employed is likely to climb to -0.6 in 2024. At this time, LakeShore Biopharma's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 661.3 M in 2024, whereas Return On Tangible Assets are likely to drop (0.32) in 2024. LakeShore Biopharma's management efficiency ratios could be used to measure how well LakeShore Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to drop to about 128.1 M in 2024
LakeShore Biopharma Workforce Comparison
LakeShore Biopharma Co, is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is now estimated at about 45,749. LakeShore Biopharma claims roughly 758 in number of employees contributing just under 2% to stocks in Biotechnology industry.
LakeShore Biopharma Co, Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. LakeShore Biopharma Co, Price Series Summation is a cross summation of LakeShore Biopharma price series and its benchmark/peer.
LakeShore Biopharma Notable Stakeholders
A LakeShore Biopharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as LakeShore Biopharma often face trade-offs trying to please all of them. LakeShore Biopharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting LakeShore Biopharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dave Chenn | CoCEO Board | Profile | |
| CFA MBA | President Officer | Profile | |
| MS MBA | Interim Director | Profile | |
| Yuan Liu | Head Research | Profile | |
| Zenaida MD | Chief Officer | Profile | |
| Gang Li | Head Sales | Profile | |
| Zhiyuan Ran | Head Department | Profile | |
| Wang Xu | Chief Officer | Profile |
About LakeShore Biopharma Management Performance
The success or failure of an entity such as LakeShore Biopharma Co, often depends on how effective the management is. LakeShore Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LakeShore management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LakeShore management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.30) | (0.32) | |
| Return On Capital Employed | (0.63) | (0.60) | |
| Return On Assets | (0.29) | (0.30) | |
| Return On Equity | (0.74) | (0.70) |
Please note, the imprecision that can be found in LakeShore Biopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LakeShore Biopharma Co,. Check LakeShore Biopharma's Beneish M Score to see the likelihood of LakeShore Biopharma's management manipulating its earnings.
LakeShore Biopharma Workforce Analysis
Traditionally, organizations such as LakeShore Biopharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare LakeShore Biopharma within its industry.LakeShore Biopharma Manpower Efficiency
Return on LakeShore Biopharma Manpower
| Revenue Per Employee | 756.5K | |
| Revenue Per Executive | 71.7M | |
| Net Loss Per Employee | 571.9K | |
| Net Loss Per Executive | 54.2M | |
| Working Capital Per Employee | 133.2K | |
| Working Capital Per Executive | 12.6M |
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.